Rivo Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: people who want injectable or oral compounded GLP-1 bundled with coaching and insurance-concierge support
Rivo Health is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members, Trustpilot 4.7) offering compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo for semaglutide and $199/mo for tirzepatide with deeper discounts on 3- and 6-month plans. Beyond the medication it bundles dietitians, live workouts, support groups and mental-health coaching, runs an insurance concierge to maximize coverage, and is FSA/HSA eligible. It also spans ED, longevity (NAD+, sermorelin), sleep, hair and skin, and uses partner compounding pharmacies it doesn't name.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rivo Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Rivo Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo (Starting $149/mo (Spring sale, up to ~50% off retail); 3-mo and 6-mo plans save more)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Rivo Health
Each dimension is scored algorithmically from Rivo Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $149/mo, Rivo Health runs about 12% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.7/10Rivo Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.9/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-12).
Accessibility10%
8.2/10Rivo Health treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
7.3/10Coaching/dietitian access included.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rivo Health review
Last checked July 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Rivo Health
We walked Rivo Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online assessment/intake questionnaire.
- 2Choose a plan and check out.
- 3A Rivo Health clinician meets with you after checkout to determine if you qualify for a prescription.
- 4If prescribed, medication ships with fast, discreet delivery.
- Monthly pricing is displayed upfront on a comparison table before any intake: Semaglutide from $149/mo, Tirzepatide from $199/mo, with cheaper annual plans.
- Membership is included free; plans advertise unlimited provider visits and 1-on-1 dietitian/journey support.
- Payment (checkout) comes before the clinician qualification review, so you pay before confirmed approval.
- Shipping described only as 'fast & discreet' / 'discreet delivery' with no stated timeframe or cost.
- No refund/cancellation policy was stated on the pages observed.
Rivo Health customer support
- Phone
- 1 (800) 705-8140
- hello@rivohealth.co
GLP-1 medications Rivo Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Starting $149/mo (Spring sale, up to ~50% off retail); 3-mo and 6-mo plans save more
Oral semaglutide option, same starting price as the injection
Starting $199/mo (Spring sale); multi-month plans save more
Oral tirzepatide option, same starting price as the injection
Ready to get started?
Plans and promotions change often — check Rivo Health's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo (sema) and $199/mo (tirz)
- Bundles dietitians, live workouts, support groups and mental-health coaching with the medication, not just a prescription
- Insurance concierge to maximize coverage, FSA/HSA eligible, with multi-month plans that cut the price further
- Large, established program (115,000+ members, Trustpilot 4.7) available nationwide
Watch-outs
- Uses partner compounding pharmacies it doesn't name on the site
- Headline prices are Spring-sale rates — everyday cost is higher and the deepest discounts need a 6-month commitment
- Weight loss is one of several verticals (ED, longevity, sleep, hair, skin), not a single focus
- Some bundled perks (e.g. meal prep) are paid add-ons rather than included
Is Rivo Health worth it? Our verdict
Rivo Health positions itself around one thing: people who want injectable or oral compounded GLP-1 bundled with coaching and insurance-concierge support. It runs $149/month, flat across every dose — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
Beyond the core GLP-1 program, Rivo Health leans on Injection & oral options, Insurance concierge, and FSA/HSA eligible.
How much Rivo Health actually costs
- semaglutide — $149/month
- Oral semaglutide — $149/month
- tirzepatide — $199/month
- Oral tirzepatide — $199/month
That puts Rivo Health below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Found (about $149/month) is one of the closest alternatives to weigh Rivo Health against.
Medications: what Rivo Health prescribes
Rivo Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Rivo Health's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Rivo Health is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
- want coaching and follow-up included, not sold separately.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Rivo Health treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Rivo Health earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Rivo Health is a solid telehealth option with balanced features and pricing.
Ready to start with Rivo Health?
Starting at $149/month. See current pricing and start your free consultation.
Rivo Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rivo Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rivo Health's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.